A series of studies at the UNC School of Medicine found that steroid drugs, known for inducing bone loss with prolonged use, actually help suppress a molecule that’s key to the rapid bone loss process.
A University of North Carolina School of Medicine study may have implications for thwarting the effects of bioterrorism attack with lethal microbes, as well as finding a way to save people in septic shock, an overwhelming bacterial infection of the blood.
The UNC team led by Norman Sharpless, MD, Wellcome Distinguished Professor of Cancer Research and Deputy Cancer Center Director, has developed a strain of mice that turns on a gene from fireflies when the normal p16 gene is activated.
Research findings from the University of North Carolina School of Medicine are shining a light on an important regulatory role performed by the so-called dark matter, or “junk DNA,” within each of our genes.
The study, published December 27, 2012 by the journal Molecular Cell, implicates a unique class of proteins called polycomb-like proteins, or PCL's, as bridging molecules between the "on" and "off" state of a gene.
William Y. Kim, MD, assistant professor in the departments of medicine and genetics at the University of North Carolina School of Medicine and member of UNC Lineberger Comprehensive Cancer Center, will receive $250,000 during the two-year grant term.
Researchers in the laboratory of Stanley M. Lemon, MD, outline the critical role the microRNA known as miR-122 plays in the life cycle of the hepatitis C virus.
As program leader, Dr. Kurt Ribisl will coordinate program member effort and related Cancer Center resources that facilitate faculty research.
Terry Magnuson served as vice-chair of the Institute of Medicine commission on the California Institute of Regenerative Medicine (CIRM), whose report was released on Dec. 6.
In his new role, Dr. Sharpless will be responsible for guiding the Center’s scientific agenda across the basic, clinical and population sciences.
Stacey Anderegg is an Hematology/Oncology Infusion Nurse at the N.C. Cancer Hospital. In her life outside the hospital, Stacey is a vocalist with a 7-woman a cappella group called "Stella."
The Single Fathers Due to Cancer Program includes a website and monthly support group for fathers and their children.
The consortium, which involves four partnering institutions, will support early-career scientists and clinicians during a yearlong research fellowship at 17 sites in 13 countries in Africa, Asia, and South America.
Patient perspective key to adequate evaluation of cancer treatment
Asheville artist Ann Hartline was featured in Family House Diaries in July 2011. Despite new medical challenges over the past year, Ann celebrated five years of living life large with metastatic breast cancer.
This year’s awards will be presented to Hyman B. Muss, MD, Professor of Medicine and the Director of the Geriatric Oncology Program at UNC Lineberger Comprehensive Cancer Center, and Yosef Yarden, PhD, Harold and Zelda Goldenberg Professor of Molecular Cell Biology at the Weizmann Institute of Science in Rehovot, Israel.
Researchers from UNC unveil an analysis framework aimed at helping clinicians spot “medically actionable findings” from genetic tests in an efficient manner.
Preclinical testing a necessary step in drug development
Carey named Division Chief of Hematology-Oncology in the Department of Medicine and Physician-in-Chief of the N.C. Cancer Hospital
Lisa A. Carey, MD, a nationally-recognized clinical researcher and physician, will take on her new responsibilities immediately.
Team identifies genetic causes and similarity to ovarian cancer